In the original version of this article (1), Fig. 2C, the left-most image in row 5 representing the day 30 time point for the group of mice treated with BCMA-41BBζ[2A]GPRC5D-CD28ζ was inadvertently duplicated to row 4 representing the same time point for the mice treated with GPRCD-BCMA-41BBζ. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
Reference
- 1. Fernández de Larrea C, Staehr M, Lopez AV, Ng KY, Chen Y, Godfrey WD, et al. Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape–driven relapse in multiple myeloma. Blood Cancer Discov 2020;1:146–54. [DOI] [PMC free article] [PubMed] [Google Scholar]